SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Positive topline weight-loss maintenance data for Viking Therapeutics' obesity candidate VK2735 is driving the surge in attention, with retail sentiment turning extremely bullish as bulls tout the results as best-in-class and argue the program is now de-risked. The stock's comparatively muted reaction has split the community between longs citing heavy short interest, squeeze potential, and renewed buyout or partnership speculation, and traders treating the move as a sell-the-news event that fell short of some analyst expectations.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending on heavy retail speculation after founder Patrick Soon-Shiong teased a potential push into blockchain-based tokenized stock trading at Nant, with many traders framing potential IBRX tokenization as a way to eliminate naked short selling and pressure the heavily shorted stock. Skeptics in the community dismiss the tease as unconfirmed hype and want therapeutic news instead, while chatter about Soon-Shiong meeting Turkey's president and a January PDUFA date is fueling additional speculation about possible Anktiva catalysts.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

UBER is trending as traders question why the stock keeps selling off at the open and staying red despite a stream of positive developments, most prominently CEO Dara Khosrowshahi's $10 million open-market share purchase and a roughly $5.3 million buy by the COO. The community is split between reading the insider buying, along with Bill Ackman's disclosed bullish stake, as accumulation at a bottom, and attributing the weakness to autonomous-vehicle competition fears around Tesla and Waymo robotaxis, suspected short-selling pressure or manipulation, and some citing uncertainty over the Delivery Hero acquisition financing.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Discussion is fragmented across several catalysts, led by an unconfirmed reported deal for RCL to acquire Sandals Resorts that traders linked to a sharp sell-off; critics called it a dilutive, debt-funded misstep while defenders argued the reaction was overdone for a highly profitable company. Other recurring themes include cruise-sector travel fears tied to a rare hantavirus ship outbreak, oil and marine-fuel cost swings with debate over RCL's hedging advantage versus unhedged peers like CCL, and widespread claims that short sellers and algorithms, not fundamentals, are driving the moves.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Discussion centers on Innodata's appointment of former NSA director Michael Rogers to its board and its positioning in AI safety evaluation and red-teaming, which some traders credit for the stock's sharp rally while others argue the move is technical momentum or a short squeeze rather than news-driven. Sentiment is further split between bulls citing accelerating AI-data fundamentals and bears pointing to bearish chart patterns, with bond-market and macro chatter largely acknowledged as market-wide rather than INOD-specific.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid a steep, sustained share decline following its removal from the S&P 500, with traders split on whether index-related selling drove the drop or was largely priced in as growth slows. Heavy short interest is fueling speculation of a potential short-covering rally, while criticism of managementover executive share sales, option repricing, and competition from Amazon, Google, and Metadrives much of the bearish commentary.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid a sustained run-up that traders are largely tying to CEO Ryan Cohen's continued open-market share purchases, including a roughly $26 million addition to his stake, which has fueled short-squeeze speculation and debate over the company's warrants. Community reaction is split: some view Cohen's buying as a signal of conviction, others claim the stock is being suppressed by market makers and short sellers, and a few question how much of the rally can really be attributed to insider buying.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

IOVA is drawing heavy attention as the stock stages a sharp rally out of the low single digits toward the $10$11 area, with traders split over whether the move reflects institutional accumulation, a building short squeeze, or options-related hedging. Much of the discussion is anchored to anticipated company catalysts  revised revenue guidance and Amtagvi's commercial expansion toward roughly 110 authorized treatment centers with broader payer coverage  which bulls argue are needed to sustain the move.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is drawing heavy attention after a sharp rally to multi-year highs on a large quarterly revenue beat (roughly $32M versus ~$12M expected), which traders credit to the early commercial ramp of Yartemlea (narsoplimab) against a still-small ~$1.5B market cap. The heavily bullish discussion centers on whether elevated short interest could fuel a squeeze if shares break $20, with competing debate over EU re-examination hopes, possible buyout interest, and caution from some that the crowd may be getting ahead of the fundamentals.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry's first Alloy Kore design win is dominating the conversation, with Coreturathe software-defined vehicle platform venture founded by Daimler Truck and Volvo Groupselecting the jointly developed QNXVector operating system in what the company calls the largest design win in QNX history, a nine-figure addition to the QNX royalty backlog that lands ahead of the company's upcoming Q2 earnings report. The community is split: bulls tout the win as validation of QNX's automotive and physical-AI growth story and anticipate a strong earnings report, while skeptics point to a price reaction that faded from an early pop, question how quickly backlog converts into actual revenue, and attribute the weak action to alleged manipulation or short-selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Labcorp Holdings Stock Dropped Today

Key PointsMedicare and Medicaid have been overpaying Labcorp for years, says the government...

Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day

Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day PR Newswire BURLINGTON, N.C., Sept. 10, 2026 Reaffirms full-year 2026 guidanceProvides...

Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update

Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update PR Newswire NEW YORK, Sept. 9, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Sept. 9, 2026 /PRNewswire/ -- The New...

Labcorp To Acquire MLM Medical Labs

(RTTNews) - Labcorp Holdings Inc. (LH), a laboratory services provider, on Tuesday announced that it has acquired MLM Medical Labs, a central and specialty laboratory provider with operations across the United States, Germany, and South Africa. Financial terms of the transaction...

Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials

Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials PR Newswire BURLINGTON, N.C., Sept. 8, 2026 Acquisition...

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity Labcorp Launches Next Generation of Labcorp Global Trial Connect to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity PR Newswire...

Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference PR Newswire BURLINGTON, N.C., Aug. 28, 2026 BURLINGTON, N.C., Aug. 28, 2026 /PRNewswire/ -- Labcorp(NYSE: LH), a global leader of...

Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?

DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.

Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates through the Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS) segments. The Dx segment includes routine and specialty esoteric testing. The BLS segment consists of central laboratory and ED businesses. The company was founded in 1995 and is headquartered in Burlington, NC.

Labcorp Holdings Inc.

Labcorp Raises Full Year Guidance After Q2 Earnings Beat Wall Street Expectations: Retail Sees Rally To $330

Equity

Bearish Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Current Price	$311.48
Prev Close	$320.99
Open	$305.88
Dividend Yield	1.15%
50-Day Moving Average	$314.34
Beta	0.51
Avg. Volume	586,561.55
PE Ratio	26.54

52-Week High	$341.80
52-Week Low	$244.52
Market Capitalization	$26.03B
EPS (Annual)	$10.46
Price to Book	3.02
Revenue Per Employee	$196,502.82

Feed

News

Sentiment

Earnings

Fundamentals

Info

LH Fundamentals